Biolinq Inc.
Clinical trials sponsored by Biolinq Inc., explained in plain language.
-
New Stick-On sensor could replace finger pricks for diabetes monitoring
Disease control CompletedThis study tested a small, wearable sensor that sits just under the skin and measures blood sugar continuously for up to 5 days. 247 adults with diabetes wore the sensor along with a standard continuous glucose monitor and took fingerstick tests. The goal was to see if the new se…
Phase: NA • Sponsor: Biolinq Inc. • Aim: Disease control
Last updated May 17, 2026 03:30 UTC
-
Painkiller interference tested on new diabetes sensor
Knowledge-focused CompletedThis study checked whether acetaminophen (Tylenol) interferes with a new continuous glucose monitor (CGM) called Biolinq. 31 adults with diabetes wore the Biolinq sensor and a standard CGM for three days. On the third day, they took acetaminophen and had their blood sugar measure…
Phase: NA • Sponsor: Biolinq Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:25 UTC